We expect to train more home-grown investigators who can confront these barriers by addressing research questions specific to the HIV epidemic in India, Emmanuel said.
The new grant the latest of three NIH Fogarty International awards to USF faculty -- was spearheaded by USF Healths Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease (SPAIID) and the USF-India Center for Health, HIV/AIDS Research and Training (CHART-India). Emmanuel will work with co-principal investigators Dr. Shyam Mohapatra and Dr. Eknath Naik.
The grant will expand the existing HIV infrastructure built by CHART-India. Since 1999, USF medical and public health faculty have established several CHART centers across India to care for people with HIV/AIDS, train staff and conduct research.
The Fogarty project will draw upon the expertise of USFs nationally-recognized Tampa Bay Adolescent Medicine Trials Unit. The unit, directed by Emmanuel, is one of 15 NIH-funded clinical sites across the country providing comprehensive services to HIV-infected adolescents. Emmanuel oversees a large team of researchers and clinicians who work with both adolescents and children -- educating youth at high risk for HIV in an effort to prevent AIDS, offering new treatments, and evaluating barriers to clinical trial enrollment and retention.
This prestigious grant is a national recognition of our strategic efforts to create an effective network for the globalization of translational and clinical research, said Dr. Abdul S. Rao, senior associate vice president for USF Health. It also underscores the efforts of our interdisciplinary signature program in allergy, immunology and infectious diseases, which was established last year to facilitate such activities.
'/>"/>
| Contact: Anne DeLotto Baier abaier@health.usf.edu 813-974-3300 University of South Florida Health Source:Eurekalert |